P ost-translational modifications dynamically modulate the activity, conformation states, localization, interactions, abundance and degradation of almost all proteins encoded by the human genome 1, 2 . However, most remain poorly understood since mapping the full breadth of PTM identities and locations across the entire human proteome has remained intractable 3 . Although mass spectrometry is arguably the technology best suited for direct, largescale PTM measurement, most global PTM studies have focused on modifications for which optimized enrichment workflows exist 4 . Consequently, our current view of the collective impact of PTMs on the human proteome is heavily skewed towards a small fraction of the potential PTM landscape 5 . Despite this, PTM-containing peptides are readily detected by routine tandem mass spectrometry (MS/MS) experiments, but are believed to comprise much of the 'dark matter' in proteome datasets that consistently evades reliable identification 6 . Search parameters used by most MS/MS search approaches strike a compromise between the diversity of discoverable modifications, the time needed to interpret MS/MS datasets and the ability to distinguish correct from incorrect assignments. Strategies that constrain the number of proteins being searched, apply protease specificity rules or minimize the allowable types and numbers of PTMs partially address this compromise 7 . In practice, however, these approaches only marginally decrease search times and still do not distinguish correct from incorrect PTM assignments 8 . Here, we describe TagGraph, a computational tool that addresses these limitations in two ways. First, TagGraph leverages accurate de novo mass spectrum interpretations 9 , efficient string-based indexing 10 and a graph-based string reconciliation algorithm to rapidly search MS/MS datasets without restricting the number of proteins, PTMs or protease specificities. Second, by replacing conventional 'target-decoy' error estimation 11 with a PTM-optimized probabilistic model, we can accurately discover and discriminate high-confidence peptide identifications from large search spaces. Combined, these advances make possible unconstrained surveys of large MS/MS datasets. Our analyses expand the number of known modification sites for certain PTM types by as much as 30-fold, particularly those lacking biochemical enrichment techniques. We show that TagGraph enables unbiased and rapid proteome-wide PTM characterization.
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PTMs and other sequence alterations that co-occur on a single peptide sequence without anticipating them a priori (Supplementary Note 1). Modification masses localized to specific amino acids are cross-referenced with the Unimod resource 3 to suggest the modification's identity based on mass and amino acid specificity. In this way, TagGraph effectively searches all possible sequence alterations on time scales and search sensitivities commensurate with conventional database search tools (see Fig. 1d ,e and Dataset 1 (on our webpage https://taggraph.page.link/Datasets)).
TagGraph surveys very large sequence spaces that would be impractical to query using traditional database search engines and other flexible search methods. Our strategy contrasts with previous approaches including sequence tag filtering 12 , iterative search 13 , precursor mass shift 14, 15 and spectrum clustering 16 (Supplementary Note 2). Compared to an equivalent database search, these approaches reduce the number of peptides considered per mass spectrum (or vice versa for spectrum clustering). However, these are subject to similar speed limitations as they consider larger numbers of amino acid modifications and variants. As a result, most are prone to impractically long search times (Supplementary Note 2). TagGraph addresses this obstacle by shifting the computational burden of generating many numerical pattern comparisons to an efficient string-matching and reconciliation procedure. We measured the resulting speed advantage by comparing TagGraph's execution , pNovo 55 and PepNovo 56 on a dataset of 168,391 MS/MS spectra derived from the A375 melanoma cell line (n = 12 fractions evaluated in parallel). Central line denotes medians; whiskers indicate the 1.5 interquartile range and circles indicate data points outside this range. c, TagGraph's longest-matching substring criterion (Supplementary Fig. 1 and Supplementary Note 1) yields very few candidate sequences for subsequent refinement and scoring. Heat map depicts the number of candidate peptide matches per spectrum (y axis) versus the longest-matching substring used for candidate retrieval. Over 50% of all spectra considered by TagGraph from the A375 dataset were selected from fewer than six candidates, and over 50% matched with substring lengths greater than six amino acids. d, TagGraph considered an entirely unrestricted peptide search space (black) with respect to protease specificity, range of modifications, number of modifications per peptide and number of proteins. The same A375 dataset was searched with conventional and expanded database search methods, but with one or more major (white) or modest (gray) space restrictions. Restrictions were selected to approach TagGraph's unrestricted parameters while allowing each search engine to execute without failure (see Methods). e, The combined de novo sequencing and TagGraph search times on the A375 dataset were 4.3-fold shorter than previously described expanded modification and iterative search strategies, even when the latter were given considerably reduced search spaces (Fig. 1d) . Search rates for TagGraph and PEAKS-PTM included the preliminary de novo sequencing step using PEAKS (red; 0.51 s per spectrum). Excluding the de novo step, TagGraph was 17.9-fold faster than the next-ranked search method. The asterisk represents extrapolated values: Byonic was run on just 1/12 of the A375 dataset due to search speed limitations (see Methods and Dataset 1 (https://taggraph.page.link/Datasets)).
time to five algorithms designed to consider greatly expanded search spaces [12] [13] [14] [15] 17 , and found that none could execute on both the entire dataset and the search space considered by TagGraph in this comparison. Recognizing that most of these methods were not designed to consider such unrestricted parameters, we provided them with a reduced number of spectra, search spaces or both. Nevertheless, TagGraph was 4-to 18-fold faster than any other algorithm, depending on whether we considered its preliminary de novo sequencing step (Fig. 1d,e) . We note that more restrictive search parameters than those tested here could be expected to produce substantially faster search times for some of these previous methods. In contrast, however, TagGraph has just one unrestricted operation mode, removing the need for researchers to choose between search speed and search depth.
Hierarchical Bayes model for decoy-free error estimation. Indexed-string searches solve the conflict between search speed and search depth, but exacerbate the challenge of estimating reliable false discovery rates (FDRs). The standard target-decoy estimation method we previously developed 11 is unsuitable for unconstrained search results since it loses discrimination accuracy as more peptides and PTMs are considered (Supplementary Note 3) 8, 18, 19 . Consequently, we developed a probabilistic validation strategy using a hierarchical Bayes model optimized by expectation maximization (EM) ( Supplementary Figs. 2 and 3 ) 20 . Our model deduces the likelihood that any individual peptide-spectrum match is correctly interpreted based on 14 quantitative and categorical attributes (Supplementary Note 4.B); of these, half relate specifically to modified peptides. Consequently, our model concurrently discriminates correctly and incorrectly interpreted spectra from both modified and unmodified peptides.
We first evaluated TagGraph's error model by comparing it to target (shuffled)-decoy database searching (Methods) with SEQUEST using the cell line dataset described in Fig. 1 . We found that EM-based scoring discriminated decoys from high-confidence identifications (Fig. 2a) while generating FDR estimates which were more conservative than those inferred from target-decoy searches ( Fig. 2b and Dataset 2 (https://taggraph.page.link/Datasets)), as expected for a model that discriminates between correct and incorrect PTM assignments. Furthermore, we found that the extent to which SEQUEST and TagGraph disagreed was consistent with the estimated 1% FDR threshold we applied to both ( Supplementary  Fig. 4a ). For the majority of these disagreements, however, TagGraph-generated peptide-spectrum matches were more consistent with correct identifications based on protease specificity, algorithm-assigned scores and ion assignment ( Supplementary Figs. 4b and 5). Twelve other large datasets analyzed in a similar manner yielded comparable observations (Supplementary Analysis 1).
To further evaluate the TagGraph error model, we sought to measure how often it misassigns modifications to incorrect amino acid sites. To accomplish this, we replaced all tyrosine residues with phenylalanines (mass difference of one oxygen, 15.9995 Da) in an altered human proteome sequence database (Fig. 2c) . We reasoned that an accurate expanded search algorithm should return phenylalanine-containing peptides with an additional oxygen localized to converted phenylalanines. We benchmarked five search methods against TagGraph with this validation tool. The results of each algorithm were filtered based on target-decoy-based criteria (either the algorithm's own implementation or a linear discriminant analysis 21 ) or, for TagGraph, the hierarchical Bayes model. The proportion of peptide-spectrum matches containing unmodified phenylalanines at tyrosine positions was used to estimate both sequence-and modification-specific FDRs relative to the 1% predicted FDR. Only the TagGraph error model reliably discriminated both incorrect 'base' peptide sequences and those bearing unmodified altered phenylalanines. TagGraph reported 3.5-fold fewer inconsistencies with the expected search results than the next-best flexible search method (MODa), but with 4.3-fold greater sensitivity (Fig. 2c) . These data suggest that both incorrect sequences and modifications may be common when searching multiple types of target-decoy protein databases ( Supplementary Fig. 6 ).
Stringent error tolerance often comes at the expense of overall analysis sensitivity 11 . However, we found that TagGraph doubled the number of unique peptide identifications relative to SEQUEST, in part by enabling accurate identification of peptides with any modification state. Once reconciled with Unimod, we found that unanticipated post-isolation modifications accounted for the majority of this increase (50.2% of novel modifications), followed by biologically regulated post-translational modifications (8.5%) and those with no previous association (2.1%) (Supplementary Fig 4a) . This analysis demonstrated the unique ability of TagGraph to characterize modified peptides with the speed, accuracy and sensitivity that are compatible with large-scale proteomic workflows.
To further verify the ability of TagGraph to generate bona fide PTMs, we analyzed 451,655 MS/MS spectra from a published phosphorylation-enriched dataset 22 . We first established a set of highconfidence phosphorylated peptides by searching these spectra with SEQUEST and localizing phosphates to specific amino acid residues with the A-score algorithm 23 . In parallel, we searched these spectra with the four expanded search approaches demonstrating the greatest throughput: TagGraph, Peaks-PTM, Open Search and MSFragger (Fig. 1e) . Comparing TagGraph to PEAKS-PTM, we found similar proportions of phosphorylated peptides (30 versus 31%, respectively), and agreement with high-confidence SEQUEST phosphopeptide identifications (98 versus 99%) ( Supplementary  Fig. 7 and Dataset 3 (https://taggraph.page.link/Datasets)). Furthermore, we found that TagGraph rarely (1-2%) yielded tied peptide candidates for individual spectra (Dataset 4 (https:// taggraph.page.link/Datasets) and Supplementary Table 1) , supporting the ability of our scoring model to discriminate between alternative modification configurations. The Open Search and MSFragger methods produced proportionately fewer phosphopeptide identifications (24 and 22%, respectively) that were not inherently localized to specific amino acids due to the general nature of this approach (Supplementary Note 2).
The broad modification landscape of the human proteome. To demonstrate the utility of TagGraph for deep PTM characterization, we re-analyzed a draft human proteome dataset 24 approximately 150-fold larger than our initial test dataset. Interpreting these 25 million tandem mass spectra-derived from 30 adult and fetal tissues and over 2,000 raw data files-would not be feasible with previously expanded search approaches, but took just six days on a single desktop computer once de novo sequencing was complete (one month of total running time). These data yielded over 1.1 million unique peptides, tripling the number originally reported using traditional database searching ( Fig. 3a and Dataset 5 (https:// taggraph.page.link/Datasets)). As with the phosphorylation dataset described above, the human proteome analysis yielded few tied spectra (Supplementary Table 1 and Dataset 6 (https://taggraph. page.link/Datasets)), further supporting our scoring and validation model. Although the analysis presented here focused on identification and FDR estimations for peptides rather than proteins, we nevertheless found evidence for 100 (Adult_CD8 + T Cells) to over 600 (Adult_gallbladder) additional proteins per tissue that were not originally reported ( Supplementary Fig. 8a and Dataset 7 (https:// taggraph.page.link/Datasets)). Several of these were corroborated by histological staining (Supplementary Fig. 8b) .
As with our cell line analysis ( Supplementary Fig. 4 ), TagGraph rescued peptides bearing at least one modification that was not considered in the original search (Fig. 3b) . A small number of post-isolation modifications (methionine oxidation, N-terminal carbamylation, carbamidomethylation and formylation) collectively accounted for 38% of modified spectra ( Fig. 3c and Table 1 ), as previously observed 12, 14, 15, 25, 26 . TagGraph rescued other commonly disregarded peptide classes, including semi-specific and non-specific trypsin cleavage and misassigned mono-isotopic precursor masses ( Fig. 3b and Supplementary Fig. 9 ). We note that these general identification classes persisted when we searched low-resolution MS/ MS spectra with TagGraph, but the overall identification success rate was reduced twofold relative to a conventional database search (Supplementary Fig. 10 and Dataset 8 (https://taggraph.page.link/ Datasets)). This coincided with decreased performance of our EM model on this dataset (Supplementary Analysis 1) . Thus, our ability to probe post-translationally modified proteomes depends on the mass resolution of the underlying MS/MS spectra.
In comparison to the handful of abundant yet biologically irrelevant post-isolation modifications, this extremely deep proteome analysis revealed a much wider array of lesser-abundant PTMs (Fig. 3c,d and Dataset 9 (https://taggraph.page.link/Datasets)). For example, we found N-terminal myristoylation, lysine hydroxylation and arginine dimethylation hundreds to thousands of times in the proteome without requiring the kind of targeted, sample-intensive enrichment procedures that have previously been essential to PTM analysis. This study confirmed 4,278 modifications previously reported in the Uniprot proteomics resource, while extending it by an additional 39,954 ( Fig. 3e and Dataset 10 (https://taggraph.page. link/Datasets)). To evaluate the extent to which marginal, incorrect identifications might disproportionately inflate our modification tally, we manually examined 100 diverse modification-bearing Supplementary Fig. 2 ). a, The A375 dataset ( Fig. 1 ) was searched against a composite target-decoy sequence database (Methods) with TagGraph and evaluated by EM (Dataset 1 (https://taggraph.page.link/Datasets)). Decoys were effectively discriminated with this approach, although the EM was blind to the decoy label in this analysis and in 12 other datasets (Supplementary Analysis 1a) . b, EM was generally consistent with, but more conservative than, target-decoy-based FDR estimates when both were applied to TagGraph results. This is expected, considering the inability of target-decoy to distinguish correct and incorrect modifications. These findings were reproduced considering 12 other datasets (Supplementary Analysis 1b) . c, The human proteome sequence database was modified, substituting every tyrosine residue with a phenylalanine (mass difference of -15.994915 Da). Unrestricted search error was estimated from the frequencies of base peptide sequences (gray) or substituted phenylalanine-containing peptides (red) reported by each algorithm that conflicted with results returned by a standard database search with SEQUEST (Methods). Only TagGraph reported results with an empirically calculated error rate close to the expected 1.99% upper limit, assuming that the results of each algorithm were filtered to a 1% FDR (Methods). Open Search methods using SEQUEST 14 and MSFragger 15 were not evaluated for incorrect PTM localization because these do not directly localize modifications to specific residue positions. Values are reported for peptide-spectrum matches as provided in Dataset 1 (https://taggraph.page.link/Datasets). The asterisk represents extrapolated values: Byonic was run on just 1/12 of the A375 dataset due to search speed limitations (see Methods).
peptide assignments from this human proteome dataset, which were assigned scores just at the threshold of acceptance. We found that only 26 were clearly incorrect as deemed by expert scrutiny, coinciding with the expected high local FDR for these proportionally rare and marginally confident identifications (Supplementary Analysis 1d, Supplementary Analysis 2 and Dataset 11 (https://taggraph.page.link/Datasets)). Comparing MS/MS spectra from these datasets to spectra derived from synthetic peptides (Supplementary Analysis 3) further served to validate 75 unexpected, yet high-scoring, identifications.
Many PTMs act as reversible switches on protein function. Their enzymatic addition and removal regulates signaling networks, protein binding and other cellular processes 2, 27 . Although more than 90% of TagGraph-identified PTMs were previously unreported, we found several known PTM-flanking sequence motifs enriched in this dataset (for example, proline-directed phosphorylation 21 and glycine-directed arginine methylation 28 ) ( Fig. 4a and Supplementary Fig. 11 ). We also identified over 200 gene ontologies that were significantly (Benjamini-corrected Fisher's exact P < 0.001) enriched among proteins bearing 22 noteworthy PTMs (Fig. 4b, Supplementary Fig. 12 and Dataset 12 (https://taggraph. page.link/Datasets)). This analysis confirmed biological processes known to be regulated by multiple PTMs 5 (for example, acetyl Lys, methyl Lys, phosphorylated Ser regulating chromatin function 27 ).
Other processes, such as the cell cycle, were associated with a much more restricted set of PTMs (phosphorylated Ser) 29 .
We found that 19 of the 22 PTMs represented in Fig. 4b were enriched in multiple biological processes or cellular compartments. For example, reversible arginine methylation dynamically regulates proteins involved in RNA splicing and stabilization 30 , as confirmed by our ontology analysis (Fig. 4b) . We observed a relative increase in the mono-and dimethylation site abundances on RNA splicing proteins such as HNRNPA3 and SFPQ in reproductive tissues and lymphocytes ( Fig. 4c and Dataset 13 (https://taggraph.page.link/ Datasets)), suggesting that these modifications have specific roles in these contexts.
Quantifying PTMs without biochemical enrichment. Since PTMs and their host proteins can be simultaneously quantified by mass spectrometry, we accordingly estimated the stoichiometry of each PTM (Methods and Dataset 14 (https://taggraph. page.link/Datasets)) 22 . This method contrasts with previous PTM , but also expanded unique peptide identities from the human proteome dataset by over threefold relative to those originally reported. b, Categorical breakdown of unique peptide forms (distinguishing PTMs) identified by TagGraph. As expected, the majority of peptides identified by both TagGraph and ref. 24 correspond to tryptic peptides. Peptides identified by TagGraph but not by ref. 24 primarily originated from non-tryptic peptides and peptides with unanticipated modifications. Post-isolation modifications comprised the most prevalent identification category in this dataset. c, Mass shifts (modified amino acid mass-unmodified amino acid mass) corresponding to all modifications identified by TagGraph from the human proteome dataset reveal a complex modification landscape. Numbers of identifications (peptide-spectrum matches) span six orders of magnitude. Despite the presence of several highly abundant post-isolation modifications (for example, formylation), the depth of the proteomic profiling achieved in this dataset made it possible to characterize lower-abundance post-translational modifications. Inset: modification frequencies without log transformation. d, Ranked relative abundances of 2,576 PTM-amino acid combinations, as estimated by the number of spectra bearing each from the human proteome dataset. Ten of these are highlighted; all modifications are represented in Dataset 9 (https://taggraph.page.link/ Datasets). e, Over 90% of modification sites (39,954 of 44,232) identified by TagGraph from the human proteome dataset were not among 52,959 previously described in Uniprot. However, the overlap in the sites reported by TagGraph and Uniprot (4,278) is highly significant (P = 1 × 10 -308
, one-tailed Fisher's exact test).
stoichiometry assays that required metabolic labeling 31 or enzymatic removal of a single target PTM class 32 . Since PTM stoichiometries can have important implications for substrate protein activity and function, deeply sequenced proteome datasets such as this are an untapped resource for measuring a wide range of protein regulation. We found that protein N-terminal acetylation demonstrated the most consistently high stoichiometry (95.5%; standard deviation = 16.7%, Fig. 4d ). This is expected, considering the broad and irreversible acetyl group addition, co-translationally catalyzed by N-terminal acetyltransferases 33 . Conversely, we found that lysine acetylation exhibited low and variable stoichiometry (15.2%; standard deviation = 22.7%, Fig. 4d ), consistent with its heterogeneous representation on histone proteins 34 , and its possible non-enzymatic origins on abundant cytosolic and mitochondrial proteins 35, 36 . We found that neither PTM abundance nor stoichiometry correlated with substrate protein abundance ( Supplementary  Fig. 13 ), supporting the complementary use of both measurements in proteome characterization.
Characterizing multiple PTM types on highly modified proteins.
TagGraph identified multiple intersecting PTMs on individual proteins, and on individual residues ( Fig. 4c and Dataset 10 a Top ten modifications of the three indicated categories are shown, ordered by the number of unique peptides identified in the human proteome dataset from ref. 24 . Categories assigned based on the probable modification identity, as determined by TagGraph. b Modification identities assigned by TagGraph, based on observed mass shifts, modification specificity and evidence in the Unimod resource.
c Specificity determined from the sites within modified peptides to which observed mass shifts were assigned. d Mass shift measured from the difference between an observed amino acid residue's mono-isotopic mass and the expected value. Negative values indicate a net mass loss. e Number of unique peptide sequences bearing the annotated modification. Does not include peptide sequences identified with multiple modifications. f Total number of spectra in which indicated modification was confidently identified. g Total number of distinct amino acid residue sites bearing indicated modification. h Hypothetical identity of mass shift.
(https://taggraph.page.link/Datasets)), with hundreds of PTMs identified on proteins such as albumin (921 PTMs) and actin (514 PTMs) (Fig. 4e) . Histones are known to undergo extensive and combinatorial modifications to encode epigenetic information 27 , but deciphering these modifications has previously required individual histone isoform 37 or specific modification 38 enrichment. Using TagGraph, we identified 273 PTMs across the five major histone proteins, 128 of which were not previously reported (Dataset 15 (https://taggraph.page.link/Datasets)). While we found that modifications such as K28 dimethylation and K80 methylation on Histone H3 were both abundant and ubiquitous across the tissues examined here (Fig. 4f) , we note several tissue-specific PTMs, such as Histone H4 R56 dimethylation, occurring with 25-fold greater abundance in fetal than in adult tissues. Twenty-six diverse PTMs showed similarly greater abundance in fetal tissues, suggesting specific roles in development (Dataset 15 (https://taggraph.page.link/Datasets)). Systematically evaluating these modifications in conjunction with the rest of the proteome, and without targeted enrichment techniques, supports the use of TagGraph for this type of secondary analysis.
Enrichment-free discovery and characterization of protein hydroxylation. We found that hydroxylated prolines, tyrosines and lysines comprised a sizeable (16%) proportion of histone PTMs (Dataset 15 (https://taggraph.page.link/Datasets)), yet only hydroxylated tyrosine was previously described 39 . Proline hydroxylation is the most abundant modification in the human body 40 , but just 321 sites have been cataloged 41 . Unlike more widely studied modifications, no enrichment methods have facilitated its focused analysis. Furthermore, of 11 amino acids capable of becoming hydroxylated 3 , four (Met, Trp, Phe, His) are often hydroxylated by sample preparation protocols. Thus, true post-translational proline hydroxylation must be distinguished from mis-localized artifacts 23 . TagGraph's modification-focused error model allowed us to identify and localize over tenfold more hydroxylproline residues than were previously known in humans (Table 1) .
Proline hydroxylation is essential to the role of collagen proteins in maintaining extracellular matrix (ECM) stability. Despite hydroxylproline comprising over 13% of mammalian collagen by weight 42 , only 254 sites across all collagens were previously assigned in humans (79% of all charted hydroxyl prolines in the human proteome). TagGraph identified 166 proline hydroxylation sites on COL1A2 alone, just four of which were previously described 43 ( Fig. 5a ). While most proline hydroxylation sites were represented across most solid tissues examined here (for example, P330, P642), several displayed tissue-specific abundance (for example, P408 restricted to colon, bladder, liver, gall bladder and pancreas) (Fig. 5b) . TagGraph identified 14 other PTM types from this single protein, suggesting multiple routes by which PTMs cooperatively regulate collagen structure and function (Dataset 16 (https://taggraph.page. link/Datasets)).
Our analysis extends known proline hydroxylation by nearly 3,000 sites spanning almost 1,000 substrate proteins (Dataset 10 (https://taggraph.page.link/Datasets)). These proteins were significantly enriched for 113 biological processes and 60 cellular compartments (Benjamini-corrected Fisher's exact P < 0.01) (Dataset 12 (https://taggraph.page.link/Datasets)), suggesting that proline hydroxylation could influence many cellular processes beyond matrix homeostasis (Fig. 4b) . Noting that tumors exploit some of these same processes during oncogenesis, we hypothesized that proline hydroxylation could play a role in cancer. Associations were previously shown between specific phosphorylation sites and cancer-associated mutations 44 and, using a similar approach, we examined whether proline hydroxylation significantly intersected with missense somatic cancer mutations cataloged in the COSMIC database 45 . We found that hydroxylated prolines were 25% more likely to be associated with cancer mutations than expected (P = 6 × 10 -11
Fisher's exact test; P < 1 × 10 -9 Bonferroni-corrected), even excluding collagens (22%, P = 4 × 10 -6 Fisher's exact test; P < 7 × 10 -5
Bonferroni-corrected) ( Fig. 5c and Datasets 17 and 18 (https://taggraph.page.link/Datasets)). Methionine oxidation, a common postisolation modification, was not enriched (P = 0.49, Fisher's exact test), nor were other post-isolation proline modifications (Fig. 5c ). Thus, further study of hydroxylation could provide insight into cancer pathogenesis and reveal alternative therapeutic targets. As with proline hydroxylation, TagGraph substantially expanded the number of known lysine hydroxylation and asparagine hydroxylation sites by 14-and four-fold, respectively. To elucidate possible direct protein-PTM interactions, we screened all PTM and protein quantifications for strong correlations across the 30 tissues examined here. We found several that confirmed known functional associations ( Fig. 5d and Supplementary Fig. 14) . Generally, we found that proteins that were highly correlated with specific modifications did not bear those modifications themselves ( Supplementary Fig.  14b ). However, these tended to be enriched for the same functional ontologies as PTM substrates (Supplementary Fig. 14c ). Such highly correlated proteins may be candidate PTM-altering enzymes (analogous to kinases) or indirect regulators (analogous to cyclins).
We found over 70 proteins that correlated highly with lysine hydroxylation across all tissues (Fig. 5d) . Many of these proteins, such as PXDN and CYGB, have known roles in oxygen transport or oxidoreductase activity ( Supplementary Fig. 14c ), supporting their . b, Significantly enriched gene ontologies associated with prevalent post-translational modifications (yellow, 1% FDR (onetailed Fisher's exact probability, Benjamini-Hochberg-corrected)). Ontologies and significances were assigned with the DAVID web tool 58 . See Dataset 12 (https://taggraph.page.link/Datasets) for the complete list of enriched ontologies. Ontologies significantly enriched among post-isolation modifications were excluded to correct for abundance-biased PTM detection ( Supplementary Fig. 12 ). c, Arginine methylation and dimethylation distribution across proteins and tissues. The 64 most abundant mono-or dimethylated Arg sites from the entire dataset are displayed across the y axis, along with corresponding protein expression levels (49 proteins). Three modification sites on HNRNPA3 and SFPQ are highlighted for their distinct arginine mono-and dimethylation patterns across the tissues, despite demonstrating near uniform protein levels. Methyl modifications on MBP and HSPA8 are highlighted for their tissue specificity and ubiquity (respectively). Proteins were ordered by hierarchical clustering. PTMs were arranged to match their substrate proteins. All methylation sites are reported in Dataset 13 (https://taggraph.page.link/Datasets). role in regulating hydroxylation PTMs. Notably, many proteins that correlated with lysine hydroxylation also correlated with asparagine hydroxylation despite no previous evidence linking these PTMs to the same biological context. ECM collagens are the major substrates for lysine hydroxylation. Though asparagine hydroxylation was not previously characterized in the ECM, TagGraph revealed 45 sites on Fibrillin-1 and Fibrillin-2 (Dataset 10 (https://taggraph.page.link/ Datasets)), both of which are ECM constituents. These data suggest that proteins correlating with both PTMs may function as general positive regulators of ECM homeostasis through structure-stabilizing hydroxylation 40, 46 .
Discussion
While conventional database searches remain the optimal strategy for restricted protein identification, improvements in de novo sequencing speed 47 b, PTMs identified in a were found to vary in abundance across tissues. Many hydroxylations displayed uniform abundance across solid tissues (that is, P330, P642), whereas others displayed tissue-specific abundance variations (P408). c, Comparison between modification and cancer mutation sites (COSMIC). The size of each bubble indicates the number TagGraph-identified modification sites that were also found to be mutated in sequenced tumors (Dataset 17 (https:// taggraph.page.link/Datasets)). The expected value and significance (one-tailed Fisher's exact test) of this overlap were determined from the background of all peptides confidently identified by TagGraph (Methods and Dataset 18). Proline hydroxylation sites significantly overlapped with mutation sites both overall (P = 6 × 10 -11 Fisher's exact test; P = 1 × 10 -9 Bonferroni-corrected) and when restricted to non-collagen domain-containing proteins (P = 4 × 10 -6 Fisher's exact test; P = 7 × 10 -5 Bonferroni-corrected), suggesting that mutation of the PTM capacity of these sites plays a role in cancer pathogenesis. d, Correlations between protein abundance and total PTM profiles across tissues ( Supplementary Fig. 14) suggest candidate regulatory enzymes and functional associations. Proteins that highly correlated with lysine hydroxylation (x axis), asparagine hydroxylation (y axis) or both are highlighted (yellow, blue and green, respectively). PLOD1 (in purple), the enzyme responsible for lysine hydroxylation in collagen, emerged among the proteins most correlated with this modification. Protein expression levels were correlated with PTM stoichiometry across all tissues (Methods). NSC, normalized spectral counts; NSAF, normalized spectral abundance factor.
real-time data acquisition speeds. We expect this capability to become increasingly important as high-resolution and high-volume mass spectrometers become more widely available. Relatedly, enrichment methods remain the optimal choice for very deep analysis of select modifications but we expect this requirement will greatly diminish as instrumentation sensitivity improves. Here, we find that given sufficiently deep MS/MS spectra, TagGraph makes otherwise un-enrichable PTMs readily measurable (Fig. 5a,b) .
TagGraph incorporates a single-pass probabilistic model that simultaneously evaluates the likelihood that a peptide's sequence and any modifications it bears are correct (Fig. 2) . This component of our approach was essential because current target-decoy error estimation methods are inherently blind to amino acid modifications 23, 48 . We demonstrate the accuracy of our error estimations with expert inspection, synthetic peptides, direct comparison to targetdecoy error estimations and secondary modification localizations. The rediscovery of known modification sites, motifs, protein-PTM relationships and functional roles for various PTMs further supports the validity of our approach. We expect this model can be further expanded for protein-level error estimation and to incorporate additional mass spectrum and peptide features attributes made possible by new data acquisition methods 49 . This kind of high-throughput, unbiased PTM discovery platform is compatible with any proteomics experiment that uses high-resolution tandem mass spectrometry. We envision applying TagGraph to many types of experiments requiring much larger sequence spaces, including metaproteomics 50 , alternative start site utilization 51 and gene prediction refinement 52 . By rapidly evaluating many candidate protein and peptide configurations, TagGraph can validate translation products that would confound conventional database search methods. TagGraph's peptide-focused output maintains compatibility with protein assembly and related post-search computations 53 , and this flexibility should have direct application to systems previously intractable to large-scale proteome analysis such as the gut microbiome and other complex microbial communities. Finally, by learning essential experimental details directly from input data, TagGraph can help standardize proteomic analyses. This could enable direct comparisons between datasets collected by multiple laboratories, thereby fostering the kind of large-scale collaborations that have transformed the genomics field.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41587-019-0067-5. 59 were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and antibiotics. Cells were detached by trypsinization, pelleted, washed with phosphate buffered saline and flash-frozen in liquid nitrogen. Flash-frozen A375 cells (5 × 10 7 ) were thawed on ice and lysed by tip sonication in urea lysis buffer (8 M urea, 100 mM NaCl, 50 mM Tris, 1 mM phenylmethanesulfonyl fluoride, 10 µM E-64, 100 nM bestatin, pH 8.2). The cell lysate was reduced (5 mM dithiothreitol, 55 °C, 30 min), alkylated (12.5 mM iodoacetamide, room temperature, 1 h in the dark) and digested overnight with protease Lys-C at an enzyme:substrate ratio of 1:100 (37 °C). The resulting peptide mixture was desalted using C-18 Sep-Pak cartridges (Waters), dried using vacuum-centrifugation and resuspended in 10 mM ammonium formate, pH 10 before high-pH reverse-phase (HPRP) separation. HPRP was performed using an Agilent 1100 binary high-performance liquid chromatography unit, delivering a gradient (0-5% B for 10 min, 5-35% B for 60 min, 35-70% B for 15 min, 70% B for 10 min) across an Agilent C-18 Zorbax Extend column. Buffer A was 10 mM ammonium formate, pH 10 and buffer B was 10 mM ammonium formate, 90% acetonitrile, pH 10. Sixty 1 min fractions were collected and concatenated into 12 fractions as described previously 60 .
Methods

A375 dataset. Sample processing. A375 melanoma cells (ATCC)
Mass spectrometry. All HPRP fractions were desalted using C-18 Sep-pak cartridges (Waters), vacuum-centrifuged and resuspended in 5% acetonitrile and 5% formic acid at approximately 1 μg μl -1
. One microgram of each fraction was analyzed by microcapillary liquid chromatography electrospray ionization tandem mass spectrometry (LC-MS/MS) on an LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scientific) equipped with an in-house-built nanospray source, an Agilent 1200 Series binary high-performance liquid chromatography pump and a MicroAS autosampler (Thermo Fisher Scientific). Peptides were separated on a 125 μm internal diameter × 18 cm fused silica microcapillary column with an in-house pulled emitter tip with an internal diameter of approximately 5 μm. The column was packed with ProntoSIL C 18 AQ reversed-phase resin (3 μm particles, 200 Å pore size; MAC-MOD). Each sample was separated by applying a two-step gradient: 7-25% buffer B for 2 h, 25-45% B for 30 min. Buffer A was 0.1% formic acid and 2.5% acetonitrile, and buffer B was 0.1% formic acid and 97.5% acetonitrile. The mass spectrometer was operated in a data-dependent mode in which a full MS scan was acquired in the Orbitrap (AGC: 5 × 10 ; minimum m/z: 100; maximum ion injection time: 1,000 ms; isolation width: 2 Da; normalized collision energy: 30; default charge state: 2; activation time: 30 ms; dynamic exclusion time: 60 s; excluded were singly charged ions and those for which no charge state could be determined). Mass calibration of the Orbitrap analyzer was maintained to deliver mass accuracies of ±5 ppm without an external calibrant. All raw mass spectrometry data were uploaded to the PRIDE repository 61 and assigned the accession No. PXD005912.
Synthetic peptide confirmation dataset. In total, 86 synthetic peptides (SpikeTides from JPT Peptide Technologies GmbH) validating various modifications and semi-or non-specific peptide assignments were evaluated. A final pool of all peptides dissolved in 0.1% formic acid was generated, and the concentration of each individual peptide was roughly 250 fmol µl -1
. Two LC-MS/ MS runs were performed and the autosampler injected 1 µl of the synthetic peptide pool. An ESI-Orbitrap Elite mass spectrometer (Thermo Fisher Scientific) interfaced with an Eksigent ekspert nanoLC 425 system (Eksigent Technologies) was used. Peptides were introduced into the mass spectrometer via a fused silica microcapillary column (100 µm inner diameter) ending in an in-house pulled needle tip. The columns were packed in-house to a length of 18 cm with a C18 reversed-phase resin (Reprosil-Pur C18-AQ resin (3 µm Dr. Maisch, GmbH)). For elution, a two-step gradient of 4-25% buffer B (5% dimethylsulfoxide, 0.2% formic acid and 94.8% acetonitrile (v/v)) in buffer A (5% dimethylsulfoxide and 0.2% formic acid in water (v/v)) over 60 min, followed by a second phase of 25-45% buffer B for 20 min, was used. The LTQ Orbitrap was operated in data-dependent mode to automatically switch between Orbitrap-MS (from m/z 340 to 1600) and ten MS/MS acquisitions. Each FT-MS scan was acquired at 60,000 full width at half-maxiumum (FWHM) nominal resolution settings, while the MS/MS spectra were acquired using HCD at a resolution of 15,000. Precursor ion charge state screening was enabled (charge state 1 rejected) and the normalized collision energy was set to 35%.
The resulting data were analyzed by TagGraph to match mass spectra with their best-matching synthetic peptide sequence. Synthetic-and experimentderived mass spectra (for example, from the draft human proteome dataset) were compared only if spectra were assigned to the same peptide sequence in the same charge state. Of the 86 peptides synthesized, 75 were matched in this manner and used to validate TagGraph peptide-spectrum assignments (Supplementary Analysis 3). The mass tolerance used to match b-and y-ions was 0.1 Da.
Phosphorylation-enriched proteome dataset.
A subset of RAW data from a recent phosphorylation analysis 22 was downloaded from the PRIDE data repository using accession No. PXD000612. The re-analysis data presented here were deposited in PRIDE with the accession No. PXD008899.
Draft human proteome dataset. All RAW data and database search results from the draft human proteome dataset 24 were downloaded from the PRIDE data repository using accession No. PXD000561. Lung-specific, low-resolution RAW data were described in the companion human proteome dataset 62 , and were downloaded from the PeptideAtlas data repository using accession No. PAe001771. The re-analysis data presented here for the dataset presented in ref. 24 were deposited in the MassIVE repository and linked with the original source identifier No. MSV000079514. The lung-specific, low-resolution data were deposited in PRIDE with accession No. PXD008902.
De novo search engine comparisons. We compared the performance of three de novo sequencing algorithms, PEAKS 7 (ref. 7) 54 , PepNovo+ (v.3.1) 56 and pNovo (v.1.1) 55 and assayed their ability to generate mostly correct sequence interpretations of high-mass accuracy MS/MS spectra 9 . Each algorithm was used to search the A375 dataset, and the resulting peptide identifications were compared against high-confidence peptide-spectrum matches obtained from a SEQUEST search of the same dataset as previously described 9 (see section target-decoy database construction and utilization, below). Static and differential modifications were set as for the SEQUEST search. Mass tolerance parameters were optimized to achieve maximum sequencing accuracy for each algorithm individually 9 . PEAKS was run with a precursor mass tolerance of 10 ppm and a fragment mass tolerance of 0.01 Da. PepNovo+ was run with 0.01 Da precursor mass tolerance and 0.05 Da mass tolerance on fragment ions; pNovo was run with 6 ppm precursor mass tolerance and 25 ppm fragment ion tolerance. These mass tolerances were previously determined to maximize sequence accuracy corresponding with our instrumentation 9 . The accuracy of each de novo algorithm was assessed using the sequence accuracy metric 9 . For a given de novo peptide-spectrum match and its corresponding high-confidence SEQUEST peptide-spectrum match, sequence accuracy represents the fraction of prefix residue masses present in the highconfidence SEQUEST match which were also present in the de novo sequence 9 .
Database search engine comparisons. Algorithm benchmarking with the A375 dataset. We assessed the ability of several expanded database search algorithms to detect undefined modifications, without constraining protease specificity, using the A375 dataset. As a baseline, we searched all 168,391 MS/MS spectra in this dataset with SEQUEST 63 (v.28 rev. 12) using an indexed sequence database comprising the human proteome (Uniprot, downloaded 9 December 2014) 64 plus common contaminants. These sequences were appended by decoy protein sequences constructed as described in the section TagGraph parameters, below. The SEQUEST search was conducted with Lys-C protease specificity, 50 ppm precursor ion mass tolerance and 0.5 Da fragment ion mass tolerance. Cysteine carbamidomethylation (+57.021464 Da) was set as a static modification, and methionine oxidation (+15.994915 Da) was set as a differential modification. FDRs were estimated with a linear discriminant method 21 . The A375 dataset was then searched using PEAKS-PTM (v.7) 17 , Byonic (v.2.5.6) 13 , ModA (v.1.03) 12 , the Open Search method using SEQUEST 14 and MSFragger (build 20170103) 15 -four distinct strategies described as being able to either consider relatively large numbers of discrete amino acid modifications or to search spectra with no a priori constraints on possible modifications. It was not possible to search the entire A375 dataset with any of the above algorithms using completely unconstrained parameters with respect to both modifications and protease specificity-either the algorithms would not execute or they did not complete within a reasonable amount of time (5 days per RAW data file). Thus, central processing unit (CPU) times (Fig. 1e) were calculated using the least restrictive parameters that were compatible with each algorithm. Search times were extrapolated from a limited subset of search results (Byonic) for which searching the entire dataset would be too computationally intensive with similar computational resources used by the other algorithms. As such, reported search times represent a substantial underestimation of the true time needed for each of these algorithms to analyze a sample in a manner equivalent to TagGraph, as described below.
PEAKS-PTM: the A375 dataset was first de novo sequenced with PEAKS using the following settings: 10 ppm precursor ion tolerance and 0.01 Da fragment ion tolerance, cysteine carbamidomethylation as a static modification and methionine oxidation as a differential modification. The dataset was then analyzed with PEAKS-PTM using the same modification and mass tolerances as for the de novo sequencing, Lys-C enzyme specificity allowing for non-specific cleavage at both ends of the peptide and considering all 485 unimod-based modifications curated in the PEAKS internal PTM database. FDRs were estimated using the PEAKS internal target-decoy method.
MODa: the A375 dataset was analyzed with the following settings: 0.05 Da precursor mass tolerance, 0.05 Da fragment ion tolerance, allowing multiple modifications per peptide, no protease specificity, modification size between -200 and 200 Da and cysteine carbamidomethylation as a static modification. FDRs were estimated using the 'anal_moda.jar' program included in the MODa software package.
Byonic: the A375 dataset was analyzed using the following settings: 10 ppm precursor ion tolerance, 20 ppm fragment ion tolerance, Lys-C protease specificity, cysteine carbamidomethylation as a static modification, methionine oxidation as a differential modification, wildcard search enabled with a minimum mass of -200 Da and a maximum mass of 200 Da. FDRs were estimated using Byonic's internal target-decoy method.
Open Search (SEQUEST): the A375 dataset was analyzed using the same search parameters as the initial SEQUEST search, except for allowing a 500 Da mass window surrounding each precursor and allowing semi-trypsin specificity. FDRs were estimated using the linear discriminant method as described above for SEQUEST.
Open Search (MSFragger): the A375 dataset was analyzed using the following settings: 500 Da precursor mass tolerance; 10 ppm precursor true tolerance; 20 ppm fragment mass tolerance; no isotope_error correction; semi-specific trypsin digestion; one missed cleavage; clipped N-terminal methionine; cysteine carbamidomethylation as a static modification; variable oxidized methionine; allow multiple modifications on one residue; allow up to three variable modifications per modification type; allow up to 1,000 variable modifications per peptide; require at least 15 fragment ion peaks per MS/MS spectrum. FDRs were estimated using PeptideProphet as originally described 15 . For the above algorithms, the target sequence database used was the same as for SEQUEST. PEAKS-PTM and Byonic were allowed to use their own internal methods for creating decoy sequences, whereas ModA and both Open Search methods were provided the same concatenated target-decoy sequence database used for TagGraph EM comparisons (see section TagGraph parameters, below). Open Search with SEQUEST used the same preprocessed sequence index as the conventional SEQUEST search. One CPU thread was used for all searches.
CPU search times (Fig. 1e) were calculated as the sum of CPU time over all processes spawned by each database search algorithm to analyze the data. Due to computational constraints, it was not possible to run Byonic with semi-specific or non-specific enzyme specificity or on the entire A375 dataset. Thus, we conducted the Byonic search with full Lys-C specificity (Fig. 1d) , and analyzed only the first fraction of the A375 dataset. The estimated CPU time over the entire dataset was extrapolated by multiplying the CPU time recorded from the analysis of a single HPRP fraction by the ratio of the total MS/MS spectra in the dataset (168,391) divided by the number of MS/MS spectra in the single fraction (16, 613) .
Unrestricted modification discovery from phosphorylation-enriched dataset.
We compared TagGraph to the highest-performing search methods emerging from Fig. 1 , PEAKS-PTM, Open Search (SEQUEST) and Open Search (MSFragger) using the Sharma et al. phosphorylation-enriched dataset 22 as well as conventional database search with SEQUEST. We searched 451,655 MS/MS spectra as described for the A375 dataset above, noting the following differences:
SEQUEST: searches were conducted with trypsin protease specificity, and phosphorylation (+79.99633) was set as a differential modification on serine, threonine and tyrosines.
PEAKS-PTM: searches applied trypsin specificity allowing for non-specific cleavage at both ends of the peptide.
Open Search (SEQUEST): searches were conducted with trypsin protease specificity.
Open Search (MSFragger): no changes relative to the A375 dataset.
Unrestricted modification discovery from low-resolution MS/MS spectra.
We evaluated the ability of TagGraph to search low-resolution MS/MS spectra, relative to standard database searching with the SEQUEST algorithm. SEQUEST searches of were performed on 336,344 MS/MS spectra corresponding with the lung dataset (PeptideAtlas data repository entry No. PAe001771) as described above, exceptthat trypsin specificity was required and fragment ion tolerance was set to null (that is, 1 Da).
Target-decoy database construction and utilization. For the purpose of comparing EM-based FDR estimations to the standard target-decoy approach (Fig.  2a,b and Supplementary Analysis 1), we concatenated human proteome sequences with decoy counterparts for target-decoy FDR estimation 11 . We previously observed that de novo sequencing algorithms occasionally mistake b-and y-ion series, and consequently have a tendency towards returning reversed sequences 9 . As a result, decoys generated by strict sequence reversal are at risk of systematically overestimating FDRs of TagGraph results: PSMs derived from incorrect, reversed de novo sequences would preferentially match decoy sequences over target sequences.
We addressed this bias by generating decoy sequences in a manner that shuffled amino acid sequences while preserving the distribution of tryptic peptides and frequencies of peptides shared between proteins: (1) protein sequences are first reversed; (2) the locations of all lysines and arginines in the reversed sequences are fixed, and the intervening sequences are shuffled; and (3) for each unique intervening pre-shuffled peptide sequence, the shuffled variant is cached and all subsequent peptide instances are mapped to the same shuffled variant. This method efficiently preserved a desired 50:50 target-decoy ratio (Fig. 2a and  Supplementary Analysis 1a) by maintaining the same number, length and mass distribution of unique Lys-C/tryptic peptides in the target and decoy databases, while removing the source of the overestimation bias described above.
False discovery rates based on the target-decoy strategy ( Fig. 2b and Supplementary Analysis 1b-d) were calculated by summing the number of decoy identifications exceeding a given EM score threshold, dividing this by the total number of identifications exceeding this threshold and then multiplying this quotient by the decoy factor we previously described to account for the slight bias we observed towards decoy identifications 11 . This factor was estimated as the proportion of low-confidence (EM score < 0) target identifications relative to all low-confidence identifications. This factor was on average 1.88, rather than the expected 2.0. Short peptides of fewer than eight amino acids in length were excluded from this analysis due to their lower information content.
TagGraph parameters.
TagGraph was used to analyze the proteome datasets described above. All available MS/MS spectra were first de novo sequenced using PEAKS as described in the section Database search engine comparisons, above, and are noted below. The resulting peptide sequences and raw mass spectra (mzXML-formatted 65 ) were given as input to TagGraph. For the A375 dataset, PEAKS was run with a precursor mass tolerance of 10 ppm and a fragment mass tolerance of 0.01 Da. To account for wider fragment mass variances for several component datasets that comprised the draft human proteome, we increased the fragment ion tolerance to 0.05 Da. This parameter was set to 1 Da for the low-resolution MS/MS lung dataset. Other parameters were consistent with the A375, phosphorylation and low-resolution lung dataset analyses: 10 ppm precursor mass tolerance cysteine carbamidomethylation as a static modification, and methionine oxidation as a differential modification. Unless otherwise specified, de novo sequencing results were searched with TagGraph against the human proteome (Uniprot, downloaded 9 December 2014) plus common contaminants with no additional decoy sequences.
The above database was concatenated with decoy sequences only for searches involving the A375 dataset, and for 12 other datasets examined in this report (see section Target-decoy database construction and utilization). Searching this target-decoy sequence database with TagGraph enabled fair comparison of the CPU times of TagGraph to the other database search algorithms (Fig. 1e) and direct comparisons of FDR estimates (Fig. 2a,b and Supplementary Analysis 1) . Otherwise, no decoys were used for TagGraph analyses.
TagGraph empirically optimizes precursor mass tolerances as part of its hierarchical Bayes scoring model. Fragment ion tolerances were initially set to 20 ppm of the precursor mass. We also define the quantity modification mass tolerance, which describes whether a particular modification agrees with one represented in the Unimod resource or a novel modification specific to the present dataset. This tolerance was set to 0.1 Da. Enzyme specificity was set to Lys-C for the A375 dataset and Trypsin for the human proteome dataset. Although enzyme specificity was considered as a scoring attribute in the hierarchical Bayes model, TagGraph is able to return high-confidence semi-specific and non-specific peptide-spectrum matches regardless of input enzyme specificity.
For the purposes of calibrating EM-and target-decoy FDR estimations, all returned peptide-spectrum matches were ranked according to their probabilities P(D|+) from highest to lowest, and the inverse values (1 -P) of these probabilities were summed in order of decreasing rank. FDRs were estimated from EM scores as described in Supplementary Note 4 and specifically equation (2) within this note. For all other purposes, we applied a probability threshold of 0.99 (log 10 (1 -P) ≥ 2), as previously described for parametric error estimation 66 -that is, an EM scoring threshold of 2.0 (Supplementary Analysis 1c,d) .
PTM error estimation with amino acid-substituted proteome. Target-decoybased error estimation accuracy declines when applied to peptide modifications and other large search spaces 19, 67 (Supplementary Note 3) . Despite this, all previously described unrestricted search algorithms rely on target-decoy to delineate sets of confidently identified spectra. To assess the degree to which estimated FDRs reflect underlying identification errors, we employed a modified human proteome sequence database in which every tyrosine residue was replaced by a phenylalanine. The mass difference between these residues (15.994915 Da) corresponds to an oxygen atom, and is a frequently observed modification on several residues (for example, methionine) while distinguishing other unmodified residues (for example, alanine and serine). Search engines capable of accurate PTM assignment and discrimination should search the tyrosine-substituted database and return phenylalanine-containing peptides modified by an oxygen atom only on those phenylalanines that were previously tyrosines. They should be able to discriminate these identifications from erroneous ones in which oxidation modifications were assigned to unaltered residues. We analyzed the A375 dataset against this modified sequence database using SEQUEST, PEAKS-PTM, Byonic, Mod and Open Search with SEQUEST and MSFragger. The results from each algorithm were then filtered to a 1% predicted FDR using target-decoy-based statistics, or a 0.99 probability threshold for TagGraph (EM score > 2.0). Byonic, MODa and PEAKS-PTM were allowed to use their own internal target-decoybased filtering procedures. Search results provided by SEQUEST were filtered using a linear discriminant method 21 . All results were compared to the initial SEQUEST search results of the unaltered sequences database, which were filtered to a 1% FDR. Identification error was assessed based on the proportion of peptides that conflicted with the high-confidence search results with respect to the overall amino acid sequence (base peptide), or to the presence of an unmodified phenylalanine at a former tyrosine position.
The A375 dataset was also analyzed with TagGraph against the phenylalaninesubstituted human sequence database. The parameters used were identical to those described in the section TagGraph parameters, above. Results were filtered to P ≥ 0.99 (EM score > 2.0) as described above.
We estimated a 2% maximum expected likelihood of conflicting identifications in Fig. 2c as follows. We consider two sets of search results of the same mass spectra such that identifications made in any one set have a 99% likelihood of being correct. Assuming that incorrect identifications are randomly distributed within each set of search results, spectra receiving the same identification from both search result sets should have a likelihood of being correct of 0.99 2 = 0.9801. Accordingly, the likelihood of an incorrect search result returned by either or both searches should be estimated as 1 -0.99 2 = 0.0199.
Abundance calculations. Protein abundance. Protein abundances were calculated using the distributed normalized spectral abundance factor (NSAF) method 68 . Briefly, the number of spectral counts originating from peptides that uniquely map to single proteins was summed over all proteins identified in an experiment. Spectral counts recorded from peptides that map to multiple proteins were distributed across all such proteins according to the proportion of spectral counts assigned to these from uniquely mapped peptides. Finally, summed spectral counts for each protein were normalized by protein length, and the sum of all protein abundances for each experimental dataset was normalized to one. Protein abundances per tissue were calculated as the average of the individual NSAF for that protein over all experiments performed on that tissue. For the purpose of this analysis, proteins were defined solely by their unique representation in the input sequence file-proteins with equal or overlapping peptide evidence are represented in Dataset 7 (https://taggraph.page.link/Datasets). For protein-level analyses relying on unique protein counts (Fig. 4b,e and Supplementary  Figs. 8, 12 and 14) , we selected a single highest-abundance entry to represent the indicated gene symbol.
Site abundance and stoichiometry. To compare modification sites between tissues, we quantified the abundance of sites using two methods: normalized spectral counts (NSC) and estimated stoichiometry. For both methods, we first generated a catalog of all confident peptide identifications that span a given modified amino acid position of a protein, regardless of modification state. The total spectral counts corresponding to all peptides containing the amino acid position (S T ), and only those corresponding to peptides containing the exact modification on the site of interest (S m ) were calculated for each experimental dataset.
The normalized spectral count of a modification site was calculated as S m divided by the number of confidently identified peptide-spectrum matches in the experimental dataset. The stoichiometry of the modification was calculated as S m divided by S T , following a previously described rationale 22 . Modification site abundances (stoichiometry or NSC) per tissue were calculated as the average of site abundances over all experiments performed on that tissue. Due to inherent difficulties in accurately reporting very low abundances with spectral counting 69 , experiments in which no peptides overlapping the site of modification were detected were not included in the average. Thus, the sum of stoichiometries of all modifications at a particular site in a particular tissue may not be normalized. Finally, the abundance, stoichiometry or normalized spectral count of a modification site was set to zero for a particular tissue if the corresponding protein NSAF was zero in that tissue.
Histology images. Eight protein and tissue combinations not previously reported 24 were arbitrarily selected, and used to query the Human Protein Atlas 70 (www. proteinatlas.org). Representative images selected by the web resource's curators were downloaded and are represented in Supplementary Fig. 8b . See figure legend for specific image attributions.
Gene ontology analysis. Gene ontology analysis was conducted using the DAVID web portal 58 . For each post-translational modification of interest, proteins bearing that modification were compiled and input as a gene list. The background list used was the Uniprot human proteome. The resulting gene ontologies were downloaded and a global FDR threshold (Benjamini-Hochberg) of 1% was used as a threshold for determining significantly enriched ontologies.
We observed that many ontologies were broadly enriched across all posttranslational modifications, and hypothesized that these were simply associated with highly abundant proteins and did not reflect true post-translational modification properties. As a control, we applied the above enrichment analysis and significance criterion to 15 post-isolation modifications and observed many ontologies that were enriched for all post-isolation modifications considered ( Supplementary Fig. 12 ). These ontologies were excluded from the set of enriched ontologies in the post-translational modification analysis (Fig. 4b and Dataset 12 (https://taggraph.page.link/Datasets)).
COSMIC dataset comparison. The COSMIC database of cancer mutations was downloaded from the resource's website 45 . These mutations were then filtered to keep only missense mutations. To account for slight protein sequence variations between COSMIC and Uniprot, we discarded mutations for which the amino acid residue at the denoted position in the Uniprot protein sequence did not match the non-mutated amino acid identity in the corresponding COSMIC entry.
We tested the significance of any overlap between COSMIC cancer mutations and TagGraph-identified modifications via Fisher's exact test. Using hydroxylated prolines to illustrate this calculation, we first identified all TagGraph-identified proteins bearing at least one proline hydroxylation and that were also represented in the COSMIC database. From these, we tabulated the number of prolines in the protein sequences (31, 603) , the number of TagGraph-identified hydroxylations among these prolines (3, 248) , the number of COSMIC-identified mutated prolines (5,005) and the number of mutated sites that were also found to be hydroxylated (645). These values were used to derive the expected number of overlapping mutated and hydroxylated sites by chance (514.4). We observed 25% more overlapping sites than would have been predicted by chance: (645 -514.4)/514.4 = 25.4%.
To guard against biases in background amino acid distributions, overlap statistics were calculated only for proteins on which both cancer mutations and the PTM of interest were detected, and only against the background of peptides confidently identified by TagGraph in the human proteome dataset. Using proline hydroxylation as an example, the number of prolines, number of hydroxylation prolines, number of mutated prolines and number of mutated and hydroxylated prolines were counted only on peptides confidently identified by TagGraph and on proteins containing both cancer mutations and proline hydroxylation. Overlapping residues were then tested for significance via Fisher's exact test (Dataset 18 (https:// taggraph.page.link/Datasets)). This analysis was carried out analogously for other types of hydroxylations (lysine, asparagine, methionine, and so on).
Protein-PTM correlation analysis. Reasoning that many of the abundances and stoichiometries of modifications will depend on specific protein-modifying enzymes, we sought to discover functional relationships between posttranslational modifications and proteins. We identified highly correlated subsets of modifications and proteins by comparing their abundances across the tissues examined here. Modification site and protein lists were first filtered to include only those identified from at least three tissues. For a particular post-translational modification of interest (for example, lysine hydroxylation), the abundance of the modification was averaged across all measured sites from all proteins within each tissue, forming a vector representing the abundance of the modification across all tissues. Similarly, for all identified proteins, the calculated NSAF was used to form an abundance vector of that protein's expression across all tissues. We next determined the Pearson correlation coefficient between all modification and protein vectors computed and filtered as described above. The proteins with the largest magnitude correlations (positive or negative) were then considered as candidates having a functional relationship with a modification of interest.
Modification abundance vectors were calculated using both modification stoichiometries and modification-normalized spectral counts. Both types of quantification were used in the correlation analysis, often yielding different results ( Supplementary Fig. 14a ). However, in both cases our analysis revealed previously described associations between proteins and post-translational modifications (for example, arginine methylation and RNA splicing proteins), supporting the validity of this analysis (Supplementary Fig. 14c ). 
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Data exclusions For our re-analysis of the phosphorylation-enriched data set, the low-resolution data set, and the human proteome using target-decoy methods, we focused on a subset of the original data files available. Files were selected without any prior notion of their contents. We selected a sufficient number of files to sufficiently test and compare our method's performance. Short peptides under 8 amino acids in length were excluded from target-decoy versus EM analyses as described in Online Methods:Target-decoy database construction and utilization.
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